@article{Hutchings_2021,<br/><span class="tab"></span> title={Glofitamab (Glofit) in Combination with Polatuzumab Vedotin (Pola): Phase Ib/II Preliminary Data Support Manageable Safety and Encouraging Efficacy in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)},<br/><span class="tab"></span> volume={138},<br/><span class="tab"></span> ISSN={1528-0020},<br/><span class="tab"></span> url={http://dx.doi.org/10.1182/blood-2021-148359},<br/><span class="tab"></span> DOI={10.1182/blood-2021-148359},<br/><span class="tab"></span> number={Supplement 1},<br/><span class="tab"></span> journal={Blood},<br/><span class="tab"></span> publisher={American Society of Hematology},<br/><span class="tab"></span> author={Hutchings,<br/><span class="tab"></span> Martin and Sureda,<br/><span class="tab"></span> Anna and Terol,<br/><span class="tab"></span> María José and Bosch Albareda,<br/><span class="tab"></span> Francesc and Corradini,<br/><span class="tab"></span> Paolo and Larsen,<br/><span class="tab"></span> Thomas Stauffer and Rueda Dominguez,<br/><span class="tab"></span> Antonio and Panchal,<br/><span class="tab"></span> Anesh and Bottos,<br/><span class="tab"></span> Alessia and Carlile,<br/><span class="tab"></span> David and Wang,<br/><span class="tab"></span> Yanjie and Filézac De L’Étang,<br/><span class="tab"></span> Audrey and Tandon,<br/><span class="tab"></span> Maneesh and Sellam,<br/><span class="tab"></span> Gila and Gritti,<br/><span class="tab"></span> Giuseppe},<br/><span class="tab"></span> year={2021},<br/><span class="tab"></span> month=nov,<br/><span class="tab"></span> pages={525–525} }